🔎 Trials Near Me

Home › Metastatic Cancer › Indiana › Indianapolis

Pag-aaral pangklinika para sa Metastatic Cancer sa Indianapolis, IN

19 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Indianapolis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Nagre-recruitPhase 1
  • IU Simon Cancer Center, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Nagre-recruitPhase 1
  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Franciscan Health, Indianapolis
  • Franciscan Health Mooresville, Mooresville · 16 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • Community Health Network, Inc, Indianapolis
  • Community Health Network, Inc., Indianapolis
  • Community Health Network, Inc., Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Nagre-recruitPhase 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Nagre-recruitPhase 3
  • Indiana University Health University Hospital, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • Community Health Network, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

Nagre-recruitPhase 1
  • Community Health Network MD Anderson Cancer Center - North, Indianapolis
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07403721

Prospective Validation of a Points Score System Predicting 30-day Survival

Nagre-recruitObservasyonal na pag-aaral
  • Methodist Hospital, Indianapolis
  • IU Health West, Avon · 13 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05100342

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • Community Cancer Center North, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • Community Cancer Center North, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07602842

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Nagre-recruitPhase 1
  • Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2
  • Community Health Network, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Nagre-recruitPhase 3
  • Research Site, Indianapolis
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Nagre-recruitPhase 3
  • Franciscan Health Indianapolis, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06216301

A Study of LY4175408 in Participants With Advanced Cancer

Nagre-recruitPhase 1
  • Community Health Network, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07046923

Evaluating Disparities in Precision Oncology

Nagre-recruitObservasyonal na pag-aaral
  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT06081517

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Nagre-recruitPhase 2/3
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Edad 18 pataas · Kalalakihan · Na-update Abr 8, 2026 · NCT04787744

Pag-aaral para sa Metastatic Cancer sa ibang lungsod

Iba pang pag-aaral sa Indianapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.